Global Gene Therapy Market Size, Status and Forecast 2018-2025 | Bluebird Bio, Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio

visionresearchreports.com adds “Global Gene Therapy Market Size, Status and Forecast 2018-2025” new report to its research database.

This report focuses on the global Gene Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gene Therapy development in United States, Europe and China.

Gene therapy is an experimental treatment that involves introducing genetic material into a persons cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a vector. The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.

Gene therapy is a method that involves introducing genetic material into a persons cells to fight or prevent diseases. In recent decades of years, researchers are paying more and more attention on it. Until today, it is still in infancy. There are many bio-technology companies entered into this market and carry on related research and development.

Get Sample Copy Of This Report @ https://www.visionresearchreports.com/report/sample/1039

These research companies are including Bluebird Bio, Sangamom, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical and Advantagene. Among them, the top 5 research companies occupied more than 85% market.

Generally, the research fees of companies are come from their collaboration partners. For example, Bayer Healthcare is the partner of Dimension Therapeutics. General, some products of these companies are in the period 3 of their pipeline.

In general, cancer diseases are still the largest application with market share over 65% in 2015. In addition, there are some companies are focus on rare diseases.

In 2017, the global Gene Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
Bluebird Bio
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical Inc.
Advantagene

Market segment by Type, the product can be split into
Ex vivo
In Vivo

Market segment by Application, split into
Cancer
Monogenic
Infectious disease
Cardiovascular disease
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Gene Therapy status, future forecast, growth opportunity, key market and key players.
To present the Gene Therapy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Gene Therapy are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

View Complete Report @ https://www.visionresearchreports.com/global-gene-therapy-market-size-status-and-forecast-2018-2025/1039

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gene Therapy Market Size Growth Rate by Type (2013-2025)
1.4.2 Ex vivo
1.4.3 In Vivo
1.5 Market by Application
1.5.1 Global Gene Therapy Market Share by Application (2013-2025)
1.5.2 Cancer
1.5.3 Monogenic
1.5.4 Infectious disease
1.5.5 Cardiovascular disease
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Gene Therapy Market Size
2.2 Gene Therapy Growth Trends by Regions
2.2.1 Gene Therapy Market Size by Regions (2013-2025)
2.2.2 Gene Therapy Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Gene Therapy Market Size by Manufacturers
3.1.1 Global Gene Therapy Revenue by Manufacturers (2013-2018)
3.1.2 Global Gene Therapy Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Gene Therapy Key Players Head office and Area Served
3.3 Key Players Gene Therapy Product/Solution/Service
3.4 Date of Enter into Gene Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Gene Therapy Market Size by Type (2013-2018)
4.2 Global Gene Therapy Market Size by Application (2013-2018)

5 United States
5.1 United States Gene Therapy Market Size (2013-2018)
5.2 Gene Therapy Key Players in United States
5.3 United States Gene Therapy Market Size by Type
5.4 United States Gene Therapy Market Size by Application

6 Europe
6.1 Europe Gene Therapy Market Size (2013-2018)
6.2 Gene Therapy Key Players in Europe
6.3 Europe Gene Therapy Market Size by Type
6.4 Europe Gene Therapy Market Size by Application

7 China
7.1 China Gene Therapy Market Size (2013-2018)
7.2 Gene Therapy Key Players in China
7.3 China Gene Therapy Market Size by Type
7.4 China Gene Therapy Market Size by Application

8 Japan
8.1 Japan Gene Therapy Market Size (2013-2018)
8.2 Gene Therapy Key Players in Japan
8.3 Japan Gene Therapy Market Size by Type
8.4 Japan Gene Therapy Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Gene Therapy Market Size (2013-2018)
9.2 Gene Therapy Key Players in Southeast Asia
9.3 Southeast Asia Gene Therapy Market Size by Type
9.4 Southeast Asia Gene Therapy Market Size by Application

10 India
10.1 India Gene Therapy Market Size (2013-2018)
10.2 Gene Therapy Key Players in India
10.3 India Gene Therapy Market Size by Type
10.4 India Gene Therapy Market Size by Application

11 Central & South America
11.1 Central & South America Gene Therapy Market Size (2013-2018)
11.2 Gene Therapy Key Players in Central & South America
11.3 Central & South America Gene Therapy Market Size by Type
11.4 Central & South America Gene Therapy Market Size by Application

12 International Players Profiles
12.1 Bluebird Bio
12.1.1 Bluebird Bio Company Details
12.1.2 Company Description and Business Overview
12.1.3 Gene Therapy Introduction
12.1.4 Bluebird Bio Revenue in Gene Therapy Business (2013-2018)
12.1.5 Bluebird Bio Recent Development
12.2 Sangamo
12.2.1 Sangamo Company Details
12.2.2 Company Description and Business Overview
12.2.3 Gene Therapy Introduction
12.2.4 Sangamo Revenue in Gene Therapy Business (2013-2018)
12.2.5 Sangamo Recent Development
12.3 Spark Therapeutics
12.3.1 Spark Therapeutics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Gene Therapy Introduction
12.3.4 Spark Therapeutics Revenue in Gene Therapy Business (2013-2018)
12.3.5 Spark Therapeutics Recent Development
12.4 Dimension Therapeutics
12.4.1 Dimension Therapeutics Company Details
12.4.2 Company Description and Business Overview
12.4.3 Gene Therapy Introduction
12.4.4 Dimension Therapeutics Revenue in Gene Therapy Business (2013-2018)
12.4.5 Dimension Therapeutics Recent Development
12.5 Avalanche Bio
12.5.1 Avalanche Bio Company Details
12.5.2 Company Description and Business Overview
12.5.3 Gene Therapy Introduction
12.5.4 Avalanche Bio Revenue in Gene Therapy Business (2013-2018)
12.5.5 Avalanche Bio Recent Development
12.6 Celladon
12.6.1 Celladon Company Details
12.6.2 Company Description and Business Overview
12.6.3 Gene Therapy Introduction
12.6.4 Celladon Revenue in Gene Therapy Business (2013-2018)
12.6.5 Celladon Recent Development
12.7 Vical Inc.
12.7.1 Vical Inc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Gene Therapy Introduction
12.7.4 Vical Inc. Revenue in Gene Therapy Business (2013-2018)
12.7.5 Vical Inc. Recent Development
12.8 Advantagene
12.8.1 Advantagene Company Details
12.8.2 Company Description and Business Overview
12.8.3 Gene Therapy Introduction
12.8.4 Advantagene Revenue in Gene Therapy Business (2013-2018)
12.8.5 Advantagene Recent Development

13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

Request To Buy This Premium Report @ https://www.visionresearchreports.com/report/cart/1039

About Us

Vision Research Reports is unquestionably an expert in providing research reports on a diverse number of subjects including Alternative and Green Energy, Chemical, Energy, Glass, Machinery, Manufacturing, and Pharmaceuticals and Materials. We cater to distinguished MNCs, private equity firms, SMEs and Chinese companies pertaining to their market research data requirements.

Contact Us

Sai Krupa
Office no.1,
shivneri nagar,
kondhwa Khurd, Pune 411048

This release was published on openPR.